基诺林会干扰甲胺素的血液中介激活
Melissa R Rosenthal1, Daniel E Goldberg1,2
1Division of Infectious Diseases, Washington University School of Medicine, Saint Louis, MO United States of America.
bioRxiv : the preprint server for biology
|September 2, 2025
概括
基于阿美西宁的组合疗法 (ACT) 与类合作药物有显著的药物相互作用. 基诺林通过阻断血红素激活来对抗阿尔特米西宁,这引发了目前疟疾治疗策略的担忧.
科学领域:
- 疟疾学
- 药理学
- 药物相互作用
背景情况:
- 基于素的组合疗法 (ACT) 对于治疗Plasmodium falciparum疟疾至关重要.
- 在ACT中,阿尔特米西宁与更长寿命的伴侣药物,通常是类药物相结合.
- 对ACT治疗失败和潜在的药物相互作用存在担忧.
研究的目的:
- 通过脉冲测试重新评估阿尔特米西宁和氨酸之间的药物相互作用.
- 研究这些相互作用的机制,重点是血红素激活.
- 评估新组合疗法的疗效.
主要方法:
- 使用脉冲测试来模仿素的短半衰期.
- 使用异构图来分析药物相互作用,包括耐药寄生虫.
- 使用小分子探针测量活寄生虫中的化学反应性血.
- 评估了环状阶段的生存测定和新组合疗法.
主要成果:
- 在二甲胺素 (DHA) 和氨酸 (CQ),piperaquine (PPQ) 和amodiaquine之间观察到显著的对抗作用.
- 在耐药寄生虫中,- DHA对抗性加剧,表现为超对抗性表型.
- 通过使细胞质血红素变得无效,发现氨酸抑制了氨酸的激活.
- 包括三重ACT在内的新组合也表现出对抗性相互作用.
结论:
- 过氧化物- 胺组合疗法可能会产生显著的药物相互作用,影响临床疗效.
- 通过隔离血红素来干扰素激活.
- 这些发现需要重新评估目前和拟议的联合抗疟疾药物策略.
相关概念视频
The Electron Transport Chain
17.3K
The electron transport chain or oxidative phosphorylation is an exothermic process in which free energy released during electron transfer reactions is coupled to ATP synthesis. This process is a significant source of energy in aerobic cells, and therefore inhibitors of the electron transport chain can be detrimental to the cell's metabolic processes.
Inhibitors of the electron transport chain
Rotenone, a widely used pesticide, prevents electron transfer from Fe-S cluster to ubiquinone or Q...
Inhibitors of the electron transport chain
Rotenone, a widely used pesticide, prevents electron transfer from Fe-S cluster to ubiquinone or Q...
17.3K
Oxidation of Phenols to Quinones
3.4K
In the presence of oxidizing agents, phenols are oxidized to quinones. Quinones can be easily reduced back to phenols using mild reducing agents. The electron-donating hydroxyl group enhances the reactivity of the aromatic ring, enabling oxidation of the ring even in the absence of an α hydrogen.
o-hydroxy phenols are oxidized to o-quinones and p-hydroxy phenols to p-quinones. Such redox reactions involve the transfer of two electrons and two protons. The reversible redox...
o-hydroxy phenols are oxidized to o-quinones and p-hydroxy phenols to p-quinones. Such redox reactions involve the transfer of two electrons and two protons. The reversible redox...
3.4K
Anticholinesterase Agents: Poisoning and Treatment
1.0K
Anticholinesterases, also known as cholinesterase inhibitors, work by blocking the breakdown of acetylcholine, leading to its accumulation in the synaptic cleft. This accumulation indirectly enhances both muscarinic and nicotinic actions. These agents are classified as reversible or irreversible based on their mechanism of action.
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
1.0K
Cholinergic Antagonists: Pharmacokinetics
558
Cholinergic antagonists—such as antimuscarinics—are available in oral, topical, ocular, parenteral, and inhalational formulations. Most antimuscarinics are oral formulations, while scopolamine is available as a topical patch, and ipratropium and tiotropium are available as inhalation aerosols or powders. Atropine, tropicamide, and cyclopentolate are topically instilled in the eye. Most antimuscarinics are lipid-soluble and readily absorbed from the gastrointestinal tract and...
558
Cholinergic Antagonists: Pharmacological Actions
1.2K
Antimuscarinic drugs block muscarinic receptors in multiple systems, including the gut, eye, smooth muscles, respiratory tract, cardiovascular, and central nervous systems. They produce similar effects with varying selectivity depending on the specific agent and tissue. Here are the key pharmacological actions of antimuscarinics:
Gastrointestinal Effects: Antimuscarinics reduce gut contractions, increase gastric emptying, and slow intestinal transit. They partly inhibit gastric acid secretion...
Gastrointestinal Effects: Antimuscarinics reduce gut contractions, increase gastric emptying, and slow intestinal transit. They partly inhibit gastric acid secretion...
1.2K
Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
645
Indirect-acting cholinergic agonists are agents that interact with the acetylcholinesterase enzyme in the synaptic cleft, preventing the breakdown of acetylcholine into choline and acetate. Consequently, the concentration of acetylcholine in the synaptic cleft increases. These agonists can be classified into reversible and irreversible inhibitors based on their duration of action.
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
645


